Thalidomide embryopathy cases in Brazil after 1965

Reproductive Toxicology

Volumn 22, Issue 1, 2006, Pages 1-2

  Paumgartten, Francisco J R ^a   Chahoud, Ibrahim ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; THALIDOMIDE;

BRAZIL; EMBRYOPATHY; ERYTHEMA NODOSUM LEPROSUM; HUMAN; LEPROSY; LETTER; PREGNANCY; RISK ASSESSMENT; TERATOGENICITY;

ADULT; BRAZIL; DRUG UTILIZATION REVIEW; ERYTHEMA NODOSUM; FEMALE; FETAL DISEASES; HUMANS; LEPROSY, LEPROMATOUS; POPULATION SURVEILLANCE; PREGNANCY; THALIDOMIDE;

EID: 33745504965     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2005.11.007     Document Type: Letter

References (5)

1. Sheskin J. Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 40 (1965) 303-306
2. Sheskin J., and Convit J. Results of a double-blind study of the influence of thalidomide on the lepra reaction. Int J Lepr Other Mycobact Dis 37 (1969) 135-146
3. Iyer C.G., Languillon J., Ramanujam K., Tarabini-Castellani G., De las Aguas J.T., Bechelli L.M., et al. WHO coordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull World Health Org 45 (1971) 719-732
4. Oliveira M.A., Bermudez J.A.Z., and De-Sousa A.C.M. Talidomida no Brasil: Vigilancia com responsabilidade compartilhada ? Cad Saude Publica. Rio de Janeiro 15 (1999) 99-112
5. Castilla E.E., Ashton-Prolla P., Barreda-Mejia E., Brunoni D., Cavalcanti D.P., Correa-Neto J., et al. Thalidomide, a current teratogen in South America. Teratology 54 (1996) 273-277